undamentalytics Newsletter
Sign in

Mangoceuticals, Inc. revenue

Mangoceuticals, Inc.'s revenue was $456,021 in fiscal 2025, down 26.0% on the year before. Since fiscal 2022 ($8,939) it has grown at a compound 270.9% a year. Over the last twelve months it was $315,227.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue9731616456315
Growth on the year before—+>999%−15.8%−26.0%—
Gross profit5432380250172
Gross margin54.3%59.0%61.7%54.9%54.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Mangoceuticals, Inc. $315,227 -38.9% —
Agape ATP Corp $1.2m -20.3% -12.8%
Akso Health Group $13.8m -6.4% —
American Shared Hospital Services $30.4m 4.0% 14.3%
Cryo Cell International Inc $31.1m -2.0% -0.1%
Haoxi Health Technology Ltd $54.8m 67.1% —

Compare with peers

Head to head: ATPC vs MGRXAHG vs MGRXAMS vs MGRX

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Mangoceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mangoceuticals, Inc.